Semnur Pharmaceuticals, Inc. (SMNR) Net income 2022–2025
Semnur Pharmaceuticals, Inc. (SMNR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$160.4MFY2025 · since FY2022: -$419,390 → -$160.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$160.4M | -3320.4% |
| FY2024 | -$4.7M | -841.5% |
| FY2023 | $632,536 | +250.8% |
| FY2022 | -$419,390 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SMNR financial trends
SMNR RevenueSMNR Net marginSMNR Gross profitSMNR Gross marginSMNR Operating incomeSMNR Operating marginSMNR Operating cash flowSMNR Free cash flowSMNR Capital expendituresSMNR Return on equitySMNR Stock buybacksSMNR Dividends paidSMNR Total assetsSMNR Total liabilitiesSMNR Shareholders’ equitySMNR overview →